Sun, Sep 14, 2014, 11:50 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, Inc. Message Board

  • l0410z l0410z Mar 7, 2013 1:54 PM Flag

    Abstracts on SGI-110

    SGI-110
    Abstract Number: 679 Presentation Title: SGI-110 and entinostat therapy reduces lung tumor burden and reprograms the epigenome

    Abstract Number: 678 Presentation Title: Evaluation of oral bioavailability and intermittent dosing schedules for pharmacodynamic effects by SGI-110, a novel subcutaneous (SQ) second generation hypomethylating agent (HMA), in male cynomolgus monkeys

    Abstract Number: 681 Presentation Title: SGI-110, a novel 5-aza-2’-deoxycytidine- containing dinucleotide, induces Cancer Germline (CG) antigen expression in Acute Myeloid Leukemia (AML) cells

    Abstract Number: 680 Presentation Title: In vivo immunomodulatory activity of SGI-110, a second generation hypomethylating agent, in hematologic malignancies

    Sentiment: Buy

 
ASTX
8.4950.000(0.00%)Oct 10 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
21Vianet Group, Inc.
NasdaqGSFri, Sep 12, 2014 4:00 PM EDT
Darden Restaurants, Inc.
NYSEFri, Sep 12, 2014 4:03 PM EDT